LabCorp
Covance CEO Joe Herring is set to be replaced by Deborah Keller, currently Executive Vice President and Group President of Covance R&D Laboratories.
Herring has been Chief Executive of the contract research organisation for more than ten years. Diagnostics company LabCorp acquired Covance earlier this year in a $6.1bn merger.
Deborah Keller has worked at Covance for 25 years and is currently responsible for all its drug development businesses across 18 sites in North America, Europe, and Asia. She holds a BSc in Chemistry and an MBA.